Assessing Mortality Models in Systemic Sclerosis-Related Interstitial Lung Disease

被引:23
|
作者
Mango, Robert L. [1 ]
Matteson, Eric L. [1 ,2 ]
Crowson, Cynthia S. [1 ,2 ]
Ryu, Jay H. [3 ]
Makol, Ashima [1 ,4 ]
机构
[1] Mayo Clin Coll Med & Sci, Div Rheumatol, Rochester, MN 55905 USA
[2] Mayo Clin Coll Med & Sci, Dept Hlth Sci Res, Rochester, MN USA
[3] Mayo Clin Coll Med & Sci, Div Pulm & Crit Care Med, Rochester, MN USA
[4] Mayo Clin, Dept Internal Med, Div Rheumatol, 200 1st St SW, Rochester, MN 55905 USA
基金
美国国家卫生研究院;
关键词
Systemic sclerosis; Interstitial lung disease; Non-specific interstitial pneumonia; Usual interstitial pneumonia; Mortality modeling; IDIOPATHIC PULMONARY-FIBROSIS; SCLERODERMA LUNG; RISK PREDICTION; STAGING SYSTEM; SURVIVAL; TRIALS; SMOKING; PLACEBO; TRENDS; COHORT;
D O I
10.1007/s00408-018-0126-6
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
The gender, age, and lung physiology (GAP) model, interstitial lung diseases-GAP (ILD-GAP) model, and the smoking history, age, and diffusion capacity of the lung (SADL) model were compared using a systemic sclerosis-ILD (SSc-ILD) cohort to evaluate which best determined prognosis. The models were applied to a cohort of 179 patients with SSc seen at a tertiary care center within 1 year of ILD diagnosis. Demographics, clinical characteristics, and mortality were recorded. The performance of the models was assessed using standardized mortality ratios (SMR) of observed versus predicted outcomes for calibration and concordance (c)-statistics for discrimination. SSc-ILD patients with usual interstitial pneumonia (31, 17%) had a higher mortality than those with non-specific interstitial pneumonia (147, 83%) (hazard ratio 2.27; 95%CI 1.03-4.97). All 3 models had comparable discrimination (c = 0.72, 0.72, and 0.71, respectively). Regarding calibration, the ILD-GAP model underestimated mortality (SMR 1.50; 95%CI 1.05-2.14). Calibration was acceptable for SADL (SMR 1.00; 95%CI 0.70-1.44) and GAP (SMR 0.90; 95%CI 0.63-1.29). The SADL model underestimated mortality in Stage I ILD. The ILD-GAP model underestimated mortality, and the SADL model underestimated mortality in certain subgroups. However, the GAP model performed well in this cohort, providing the best prognostic information for SSc-ILD.
引用
收藏
页码:409 / 416
页数:8
相关论文
共 50 条
  • [1] Assessing Mortality Models in Systemic Sclerosis-Related Interstitial Lung Disease
    Robert L. Mango
    Eric L. Matteson
    Cynthia S. Crowson
    Jay H. Ryu
    Ashima Makol
    Lung, 2018, 196 : 409 - 416
  • [2] ASSESSING MORTALITY MODELS IN SYSTEMIC SCLEROSIS RELATED INTERSTITIAL LUNG DISEASE
    Mango, R. L.
    Matteson, E. L.
    Crowson, C. S.
    Ryu, J. H.
    Makol, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 746 - 747
  • [3] Systemic Sclerosis-Related Interstitial Lung Disease
    Dalal, Samay
    Fischer, Aryeh
    Swigris, Jeffrey J.
    CURRENT RESPIRATORY MEDICINE REVIEWS, 2008, 4 (03) : 226 - 232
  • [4] Update on morbidity and mortality in systemic sclerosis-related interstitial lung disease
    Volkmann, Elizabeth R.
    Fischer, Aryeh
    JOURNAL OF SCLERODERMA AND RELATED DISORDERS, 2021, 6 (01) : 11 - 20
  • [5] Predicting Mortality in Systemic Sclerosis-Related Interstitial Lung Disease in Two Independent Cohorts
    Tashkin, D. P.
    Volkmann, E.
    Sim, M.
    Roth, M.
    Clements, P.
    Furst, D. E.
    Elashoff, R.
    Keyes-Elstein, L.
    Pinckney, A.
    Goldlmuntz, E.
    Sullivan, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [6] Difficulties in diagnosis of systemic sclerosis-related interstitial lung disease
    Vrancken, Anniek
    De langhe, Ellen
    Westhovens, Rene
    Yserbyt, Jonas
    Cottin, Vincent
    Wuyts, Wim
    RESPIROLOGY CASE REPORTS, 2015, 3 (03): : 99 - 101
  • [7] Assessing Adherence to Screening of Systemic Sclerosis-Related Lung Disease
    Herrmann, Matthew
    Aouhab, Zineb
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [8] CYCLOPHOSPHAMIDE VERSUS MYCOPHENOLATE FOR SYSTEMIC SCLEROSIS-RELATED INTERSTITIAL LUNG DISEASE
    Volkmann, E.
    Tashkin, D.
    Clements, P.
    Roth, M.
    Furst, D.
    Khanna, D.
    Tseng, C-H.
    Arriola, E.
    Elashoff, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 821 - 821
  • [9] Detection and classification of systemic sclerosis-related interstitial lung disease: a review
    DeMizio, Daniel J.
    Bernstein, Elana J.
    CURRENT OPINION IN RHEUMATOLOGY, 2019, 31 (06) : 553 - 560
  • [10] Emphysema and interstitial lung disease in systemic sclerosis-related pulmonary hypertension
    Vakhshoorzadeh, Jasmine
    Lui, Justin K.
    Sangani, Ruchika A.
    Trojanowski, Marcin A.
    Bujor, Andreea M.
    LaValley, Michael P.
    Klings, Elizabeth S.
    RESPIRATORY MEDICINE, 2023, 216